Kochi addition supports the company’s expansion in the region
Wilmington, N.C., 17 January 2024 — Catalyst Clinical Research announces the opening of an office in Kochi, India. The new location supports the expansion of Catalyst’s operations in India after its 2023 acquisition of Genpro Research, which supplies next-generation services and AI technology.
This office addition is an exciting new chapter for our growing India operations. Like the Trivandrum office, Kochi will be shared by both Catalyst services and the Genpro Research product team.
“We are pleased that our new space in Kochi will provide the Catalyst team with a key location from which to collaborate and connect with clients and colleagues,” said Nik Morton, COO of Catalyst Clinical Research. “Modeled after the existing Catalyst office in Trivandrum, the Kochi workplace will support our continued growth in the country.”
In addition to employees with experience in data management, biometrics, medical writing, and real-world evidence, the Kochi office will host members of the People Operations team.
